Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?

Immunogenetics

Volumn 62, Issue 4, 2010, Pages 231-235

  Hoffmann, Christina ^a   Hoffmann, Peter ^a   Lun, Andreas ^a   Büning, Carsten ^a   Hiepe, Falk ^a   Scherer, Hans U ^a   Steinhagen Thiessen, Elisabeth ^a   Weimann, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Crohn's disease; Mannan binding lectin; Mannose binding lectin; Ulcerative colitis

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; HYDROXYCHLOROQUINE; MANNAN BINDING LECTIN; MESALAZINE; METHOTREXATE; MYCOPHENOLIC ACID; SALAZOSULFAPYRIDINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; DNA; MANNOSE BINDING LECTIN; MBL2 PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; ENTERITIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHEUMATIC DISEASE; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; PROGNOSIS; RHEUMATIC DISEASES; YOUNG ADULT;

EID: 77950598976     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-010-0429-0     Document Type: Article

References (19)

1. JC Barrett S Hansoul DL Nicolae, et al. 2008 Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease Nat Genet 40 955 962 10.1038/ng.175 1:CAS:528:DC%2BD1cXptFSqs7k%3D 18587394
2. I Ferreiros-Vidal J Garcia-Meijide P Carreira, et al. 2003 The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus Rheumatology 42 570 574 10.1093/rheumatology/keg192 1:CAS:528:DC%2BD3sXit12lsLw%3D 12649405 (Pubitemid 36432477)
3. P Garred M Harboe T Oettinger, et al. 1994 Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 21 125 131 10.1111/j.1744-313X.1994.tb00183.x 1:STN:280:DyaK2s3lt12lug%3D%3D 9098426
4. P Garred HO Madsen B Hofmann A Svejgaard 1995 Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency Lancet 346 941 943 10.1016/S0140-6736(95)91559-1 1:STN:280:DyaK28%2Fgs1Sjsg%3D%3D 7564730
5. RJ Greenstein 2003 Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease Lancet Infect Dis 3 507 514 10.1016/S1473-3099(03)00724-2 12901893 (Pubitemid 36919097)
6. N Guo T Mogues S Weremowicz, et al. 1998 The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10 Mamm Genome 9 246 249 10.1007/s003359900735 1:CAS:528: DyaK1cXhslOhtbw%3D 9501312 (Pubitemid 28165433)
7. JP Hugot M Chamaillard H Zouali, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 10.1038/35079107 1:CAS:528:DC%2BD3MXksVShtLY%3D 11385576 (Pubitemid 32531408)
8. F Larsen HO Madsen RB Sim, et al. 2004 Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein J Biol Chem 279 21302 21311 10.1074/jbc.M400520200 1:CAS:528:DC%2BD2cXjvV2ntbY%3D 14764589 (Pubitemid 38656537)
9. HO Madsen P Garred S Thiel, et al. 1995 Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein J Immunol 155 3013 3020 1:CAS:528:DyaK2MXnvFCit7s%3D 7673719
10. A Rector P Lemey W Laffut, et al. 2001 Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease Genes Immun 2 323 328 10.1038/sj.gene.6363784 1:CAS:528:DC%2BD3MXnvVGjsbc%3D 11607788 (Pubitemid 33674244)
11. F Seibold A Konrad B Flogerzi, et al. 2004 Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease Gastroenterology 127 1076 1084 10.1053/j.gastro.2004.07.056 1:CAS:528:DC%2BD2cXpsVOitrk%3D 15480986 (Pubitemid 39345877)
12. C Søborg HO Madsen AB Andersen, et al. 2003 Mannose-binding lectin polymorphisms in clinical tuberculosis J Infect Dis 188 777 782 10.1086/377183 12934195 (Pubitemid 37115192)
13. JA Summerfield S Ryder M Sumiya, et al. 1995 Mannose binding protein gene mutations associated with unusual and severe infections in adults Lancet 345 886 889 10.1016/S0140-6736(95)90009-8 1:STN:280:DyaK2M3itlSntQ%3D%3D 7707811
14. M Super S Thiel J Lu, et al. 1989 Association of low levels of mannan-binding protein with a common defect of opsonisation Lancet 2 1236 1239 10.1016/S0140-6736(89)91849-7 1:STN:280:DyaK3c%2FmsFOruw%3D%3D 2573758 (Pubitemid 19284122)
15. R Takahashi A Tsutsumi K Ohtani, et al. 2005 Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus Ann Rheum Dis 64 311 314 10.1136/ard.2003.020172 1:CAS:528:DC%2BD2MXhvFyrurk%3D 15647440 (Pubitemid 40193635)
16. RJ Xavier DK Podolsky 2007 Unravelling the pathogenesis of inflammatory bowel disease Nature 448 427 434 10.1038/nature06005 1:CAS:528: DC%2BD2sXotFajurs%3D 17653185 (Pubitemid 47123518)
17. H Ytting IJ Christensen S Thiel, et al. 2007 Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise Scand J Immunol 66 458 464 10.1111/j.1365-3083.2007.01991.x 1:CAS:528:DC%2BD2sXht1Wms7bM 17850591 (Pubitemid 47394561)
18. E Zimmermann-Nielsen G Baatrup O Thorlacius-Ussing, et al. 2002 Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE. Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma Scand J Immunol 55 105 110 10.1046/j.1365-3083.2002.01035.x 1:CAS:528:DC%2BD38XitFOjurg%3D 11841698 (Pubitemid 34227264)
19. E Zimmermann-Nielsen J Agnholt O Thorlacius-Ussing, et al. 2003 Complement activation in plasma before and after infliximab treatment in Crohn's disease Scand J Gastroenterol 38 1050 1054 10.1080/00365520310005767 1:CAS:528:DC%2BD3sXosVGiurk%3D 14621279 (Pubitemid 37352468)